Sector revisions CureVac N.V.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-13 pm EDT			5-day change	1st Jan Change
5.570 ^USD	-0.54%		+26.30%	+63.34%

Jun. 13	Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target	MT
Jun. 13	CUREVAC : Downgraded to Neutral by Jefferies	ZD

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	CUREVAC N.V.							4
	LONZA GROUP AG							22
	IQVIA HOLDINGS INC.							19
	CELLTRION, INC.							22
	EUROFINS SCIENTIFIC SE							14
	TEMPUS AI, INC.							10
	ICON PUBLIC LIMITED COMPANY							15
	MODERNA, INC.							22
	ASCENDIS PHARMA A/S							16
	QIAGEN N.V.							15
	MEDPACE HOLDINGS, INC.							11
	BLUEPRINT MEDICINES CORPORATION							15
	BIO-TECHNE CORPORATION							13
	REVOLUTION MEDICINES, INC.							11
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.							17
	HANGZHOU TIGERMED CONSULTING CO., LTD							13
	PHARMARON BEIJING CO., LTD.							11
	IONIS PHARMACEUTICALS, INC.							26
	Average							15
	Weighted average by Cap.							18